nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP1A2—Carmustine—lymphatic system cancer	0.158	0.282	CbGbCtD
Bupropion—CYP2E1—Mitoxantrone—lymphatic system cancer	0.128	0.229	CbGbCtD
Bupropion—CYP2C9—Teniposide—lymphatic system cancer	0.0957	0.171	CbGbCtD
Bupropion—CYP3A4—Cytarabine—lymphatic system cancer	0.0565	0.101	CbGbCtD
Bupropion—CYP3A4—Teniposide—lymphatic system cancer	0.0557	0.0994	CbGbCtD
Bupropion—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0389	0.0695	CbGbCtD
Bupropion—CYP3A4—Vincristine—lymphatic system cancer	0.0268	0.0478	CbGbCtD
Bupropion—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000537	0.00122	CcSEcCtD
Bupropion—Oedema—Bleomycin—lymphatic system cancer	0.000537	0.00122	CcSEcCtD
Bupropion—Infection—Bleomycin—lymphatic system cancer	0.000534	0.00121	CcSEcCtD
Bupropion—Anaemia—Carmustine—lymphatic system cancer	0.000531	0.00121	CcSEcCtD
Bupropion—Back pain—Vincristine—lymphatic system cancer	0.00053	0.00121	CcSEcCtD
Bupropion—Vomiting—Teniposide—lymphatic system cancer	0.00053	0.0012	CcSEcCtD
Bupropion—Agitation—Carmustine—lymphatic system cancer	0.000528	0.0012	CcSEcCtD
Bupropion—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000526	0.0012	CcSEcCtD
Bupropion—Asthenia—Fludarabine—lymphatic system cancer	0.000526	0.00119	CcSEcCtD
Bupropion—Rash—Teniposide—lymphatic system cancer	0.000526	0.00119	CcSEcCtD
Bupropion—Dermatitis—Teniposide—lymphatic system cancer	0.000525	0.00119	CcSEcCtD
Bupropion—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000523	0.00119	CcSEcCtD
Bupropion—Headache—Teniposide—lymphatic system cancer	0.000522	0.00119	CcSEcCtD
Bupropion—Pruritus—Fludarabine—lymphatic system cancer	0.000518	0.00118	CcSEcCtD
Bupropion—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000518	0.00118	CcSEcCtD
Bupropion—Back pain—Mitoxantrone—lymphatic system cancer	0.000517	0.00117	CcSEcCtD
Bupropion—Leukopenia—Carmustine—lymphatic system cancer	0.000514	0.00117	CcSEcCtD
Bupropion—Anorexia—Bleomycin—lymphatic system cancer	0.000512	0.00116	CcSEcCtD
Bupropion—Anaemia—Vincristine—lymphatic system cancer	0.000507	0.00115	CcSEcCtD
Bupropion—Agitation—Vincristine—lymphatic system cancer	0.000504	0.00115	CcSEcCtD
Bupropion—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000503	0.00114	CcSEcCtD
Bupropion—Polyuria—Methotrexate—lymphatic system cancer	0.000503	0.00114	CcSEcCtD
Bupropion—Photosensitivity—Methotrexate—lymphatic system cancer	0.000503	0.00114	CcSEcCtD
Bupropion—Hypotension—Bleomycin—lymphatic system cancer	0.000502	0.00114	CcSEcCtD
Bupropion—Diarrhoea—Fludarabine—lymphatic system cancer	0.000501	0.00114	CcSEcCtD
Bupropion—Convulsion—Carmustine—lymphatic system cancer	0.000498	0.00113	CcSEcCtD
Bupropion—Hypertension—Carmustine—lymphatic system cancer	0.000496	0.00113	CcSEcCtD
Bupropion—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000495	0.00113	CcSEcCtD
Bupropion—Nausea—Teniposide—lymphatic system cancer	0.000495	0.00113	CcSEcCtD
Bupropion—Anaemia—Mitoxantrone—lymphatic system cancer	0.000494	0.00112	CcSEcCtD
Bupropion—Vertigo—Vincristine—lymphatic system cancer	0.000493	0.00112	CcSEcCtD
Bupropion—Leukopenia—Vincristine—lymphatic system cancer	0.000491	0.00112	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000489	0.00111	CcSEcCtD
Bupropion—Chest pain—Carmustine—lymphatic system cancer	0.000489	0.00111	CcSEcCtD
Bupropion—Myalgia—Carmustine—lymphatic system cancer	0.000489	0.00111	CcSEcCtD
Bupropion—Anxiety—Carmustine—lymphatic system cancer	0.000487	0.00111	CcSEcCtD
Bupropion—Paraesthesia—Bleomycin—lymphatic system cancer	0.000482	0.0011	CcSEcCtD
Bupropion—Malaise—Mitoxantrone—lymphatic system cancer	0.000482	0.00109	CcSEcCtD
Bupropion—Dyspnoea—Bleomycin—lymphatic system cancer	0.000479	0.00109	CcSEcCtD
Bupropion—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000478	0.00109	CcSEcCtD
Bupropion—Convulsion—Vincristine—lymphatic system cancer	0.000475	0.00108	CcSEcCtD
Bupropion—Hypertension—Vincristine—lymphatic system cancer	0.000473	0.00108	CcSEcCtD
Bupropion—Confusional state—Carmustine—lymphatic system cancer	0.000473	0.00107	CcSEcCtD
Bupropion—Oedema—Carmustine—lymphatic system cancer	0.000469	0.00107	CcSEcCtD
Bupropion—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000468	0.00106	CcSEcCtD
Bupropion—Decreased appetite—Bleomycin—lymphatic system cancer	0.000467	0.00106	CcSEcCtD
Bupropion—Myalgia—Vincristine—lymphatic system cancer	0.000467	0.00106	CcSEcCtD
Bupropion—Visual disturbance—Methotrexate—lymphatic system cancer	0.000466	0.00106	CcSEcCtD
Bupropion—Cough—Mitoxantrone—lymphatic system cancer	0.000466	0.00106	CcSEcCtD
Bupropion—Infection—Carmustine—lymphatic system cancer	0.000466	0.00106	CcSEcCtD
Bupropion—Vomiting—Fludarabine—lymphatic system cancer	0.000466	0.00106	CcSEcCtD
Bupropion—Convulsion—Mitoxantrone—lymphatic system cancer	0.000463	0.00105	CcSEcCtD
Bupropion—Rash—Fludarabine—lymphatic system cancer	0.000462	0.00105	CcSEcCtD
Bupropion—Dermatitis—Fludarabine—lymphatic system cancer	0.000461	0.00105	CcSEcCtD
Bupropion—Hypertension—Mitoxantrone—lymphatic system cancer	0.000461	0.00105	CcSEcCtD
Bupropion—Pain—Bleomycin—lymphatic system cancer	0.000459	0.00104	CcSEcCtD
Bupropion—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000459	0.00104	CcSEcCtD
Bupropion—Headache—Fludarabine—lymphatic system cancer	0.000459	0.00104	CcSEcCtD
Bupropion—Tachycardia—Carmustine—lymphatic system cancer	0.000458	0.00104	CcSEcCtD
Bupropion—Myalgia—Mitoxantrone—lymphatic system cancer	0.000455	0.00103	CcSEcCtD
Bupropion—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000455	0.00103	CcSEcCtD
Bupropion—Chest pain—Mitoxantrone—lymphatic system cancer	0.000455	0.00103	CcSEcCtD
Bupropion—Anxiety—Mitoxantrone—lymphatic system cancer	0.000453	0.00103	CcSEcCtD
Bupropion—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000451	0.00103	CcSEcCtD
Bupropion—Lethargy—Methotrexate—lymphatic system cancer	0.000451	0.00103	CcSEcCtD
Bupropion—Discomfort—Mitoxantrone—lymphatic system cancer	0.000449	0.00102	CcSEcCtD
Bupropion—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000448	0.00102	CcSEcCtD
Bupropion—Oedema—Vincristine—lymphatic system cancer	0.000448	0.00102	CcSEcCtD
Bupropion—Anorexia—Carmustine—lymphatic system cancer	0.000447	0.00102	CcSEcCtD
Bupropion—Infection—Vincristine—lymphatic system cancer	0.000445	0.00101	CcSEcCtD
Bupropion—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000443	0.00101	CcSEcCtD
Bupropion—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000442	0.001	CcSEcCtD
Bupropion—Confusional state—Mitoxantrone—lymphatic system cancer	0.000439	0.000999	CcSEcCtD
Bupropion—Nervous system disorder—Vincristine—lymphatic system cancer	0.000439	0.000998	CcSEcCtD
Bupropion—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000438	0.000996	CcSEcCtD
Bupropion—Hypotension—Carmustine—lymphatic system cancer	0.000438	0.000996	CcSEcCtD
Bupropion—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000436	0.000991	CcSEcCtD
Bupropion—Oedema—Mitoxantrone—lymphatic system cancer	0.000436	0.000991	CcSEcCtD
Bupropion—Nausea—Fludarabine—lymphatic system cancer	0.000435	0.000989	CcSEcCtD
Bupropion—Infection—Mitoxantrone—lymphatic system cancer	0.000433	0.000984	CcSEcCtD
Bupropion—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000433	0.000984	CcSEcCtD
Bupropion—Shock—Mitoxantrone—lymphatic system cancer	0.000429	0.000975	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000427	0.000971	CcSEcCtD
Bupropion—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000427	0.00097	CcSEcCtD
Bupropion—Urticaria—Bleomycin—lymphatic system cancer	0.000427	0.00097	CcSEcCtD
Bupropion—Anorexia—Vincristine—lymphatic system cancer	0.000427	0.00097	CcSEcCtD
Bupropion—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000425	0.000967	CcSEcCtD
Bupropion—Body temperature increased—Bleomycin—lymphatic system cancer	0.000425	0.000965	CcSEcCtD
Bupropion—Insomnia—Carmustine—lymphatic system cancer	0.000424	0.000964	CcSEcCtD
Bupropion—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000423	0.000963	CcSEcCtD
Bupropion—Irritability—Methotrexate—lymphatic system cancer	0.000422	0.000959	CcSEcCtD
Bupropion—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000421	0.000958	CcSEcCtD
Bupropion—Paraesthesia—Carmustine—lymphatic system cancer	0.000421	0.000957	CcSEcCtD
Bupropion—Mood swings—Methotrexate—lymphatic system cancer	0.000419	0.000952	CcSEcCtD
Bupropion—Hypotension—Vincristine—lymphatic system cancer	0.000418	0.000951	CcSEcCtD
Bupropion—Dyspnoea—Carmustine—lymphatic system cancer	0.000418	0.00095	CcSEcCtD
Bupropion—Somnolence—Carmustine—lymphatic system cancer	0.000417	0.000948	CcSEcCtD
Bupropion—Anorexia—Mitoxantrone—lymphatic system cancer	0.000415	0.000945	CcSEcCtD
Bupropion—Ataxia—Methotrexate—lymphatic system cancer	0.000415	0.000945	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000408	0.000927	CcSEcCtD
Bupropion—Decreased appetite—Carmustine—lymphatic system cancer	0.000408	0.000927	CcSEcCtD
Bupropion—Hypotension—Mitoxantrone—lymphatic system cancer	0.000407	0.000926	CcSEcCtD
Bupropion—Insomnia—Vincristine—lymphatic system cancer	0.000405	0.00092	CcSEcCtD
Bupropion—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000405	0.00092	CcSEcCtD
Bupropion—Paraesthesia—Vincristine—lymphatic system cancer	0.000402	0.000914	CcSEcCtD
Bupropion—Pain—Carmustine—lymphatic system cancer	0.000401	0.000912	CcSEcCtD
Bupropion—Constipation—Carmustine—lymphatic system cancer	0.000401	0.000912	CcSEcCtD
Bupropion—Breast disorder—Methotrexate—lymphatic system cancer	0.000399	0.000908	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000397	0.000903	CcSEcCtD
Bupropion—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000396	0.0009	CcSEcCtD
Bupropion—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000391	0.00089	CcSEcCtD
Bupropion—Decreased appetite—Vincristine—lymphatic system cancer	0.000389	0.000885	CcSEcCtD
Bupropion—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000389	0.000883	CcSEcCtD
Bupropion—Somnolence—Mitoxantrone—lymphatic system cancer	0.000387	0.000881	CcSEcCtD
Bupropion—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000386	0.000878	CcSEcCtD
Bupropion—Feeling abnormal—Carmustine—lymphatic system cancer	0.000386	0.000878	CcSEcCtD
Bupropion—Fatigue—Vincristine—lymphatic system cancer	0.000386	0.000877	CcSEcCtD
Bupropion—Asthenia—Bleomycin—lymphatic system cancer	0.000385	0.000876	CcSEcCtD
Bupropion—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000384	0.000872	CcSEcCtD
Bupropion—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000383	0.000872	CcSEcCtD
Bupropion—Pain—Vincristine—lymphatic system cancer	0.000383	0.00087	CcSEcCtD
Bupropion—Constipation—Vincristine—lymphatic system cancer	0.000383	0.00087	CcSEcCtD
Bupropion—Asthma—Methotrexate—lymphatic system cancer	0.000382	0.000868	CcSEcCtD
Bupropion—Pruritus—Bleomycin—lymphatic system cancer	0.00038	0.000864	CcSEcCtD
Bupropion—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000379	0.000861	CcSEcCtD
Bupropion—Fatigue—Mitoxantrone—lymphatic system cancer	0.000376	0.000854	CcSEcCtD
Bupropion—Pancreatitis—Methotrexate—lymphatic system cancer	0.000374	0.000851	CcSEcCtD
Bupropion—Pain—Mitoxantrone—lymphatic system cancer	0.000373	0.000847	CcSEcCtD
Bupropion—Constipation—Mitoxantrone—lymphatic system cancer	0.000373	0.000847	CcSEcCtD
Bupropion—Abdominal pain—Carmustine—lymphatic system cancer	0.000371	0.000843	CcSEcCtD
Bupropion—Body temperature increased—Carmustine—lymphatic system cancer	0.000371	0.000843	CcSEcCtD
Bupropion—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000366	0.000832	CcSEcCtD
Bupropion—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000366	0.000832	CcSEcCtD
Bupropion—Pancytopenia—Methotrexate—lymphatic system cancer	0.000363	0.000825	CcSEcCtD
Bupropion—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000359	0.000817	CcSEcCtD
Bupropion—Dysuria—Methotrexate—lymphatic system cancer	0.000357	0.000812	CcSEcCtD
Bupropion—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000356	0.00081	CcSEcCtD
Bupropion—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000355	0.000807	CcSEcCtD
Bupropion—Abdominal pain—Vincristine—lymphatic system cancer	0.000354	0.000804	CcSEcCtD
Bupropion—Body temperature increased—Vincristine—lymphatic system cancer	0.000354	0.000804	CcSEcCtD
Bupropion—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000352	0.0008	CcSEcCtD
Bupropion—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000349	0.000792	CcSEcCtD
Bupropion—Urticaria—Mitoxantrone—lymphatic system cancer	0.000346	0.000787	CcSEcCtD
Bupropion—Hypersensitivity—Carmustine—lymphatic system cancer	0.000345	0.000785	CcSEcCtD
Bupropion—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000345	0.000783	CcSEcCtD
Bupropion—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000345	0.000783	CcSEcCtD
Bupropion—Pneumonia—Methotrexate—lymphatic system cancer	0.000342	0.000779	CcSEcCtD
Bupropion—Vomiting—Bleomycin—lymphatic system cancer	0.000341	0.000776	CcSEcCtD
Bupropion—Infestation—Methotrexate—lymphatic system cancer	0.00034	0.000774	CcSEcCtD
Bupropion—Infestation NOS—Methotrexate—lymphatic system cancer	0.00034	0.000774	CcSEcCtD
Bupropion—Rash—Bleomycin—lymphatic system cancer	0.000339	0.00077	CcSEcCtD
Bupropion—Dermatitis—Bleomycin—lymphatic system cancer	0.000338	0.000769	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000338	0.000767	CcSEcCtD
Bupropion—Asthenia—Carmustine—lymphatic system cancer	0.000336	0.000765	CcSEcCtD
Bupropion—Stomatitis—Methotrexate—lymphatic system cancer	0.000332	0.000755	CcSEcCtD
Bupropion—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000331	0.000752	CcSEcCtD
Bupropion—Hypersensitivity—Vincristine—lymphatic system cancer	0.00033	0.00075	CcSEcCtD
Bupropion—Sweating—Methotrexate—lymphatic system cancer	0.000326	0.000742	CcSEcCtD
Bupropion—Epistaxis—Methotrexate—lymphatic system cancer	0.000321	0.00073	CcSEcCtD
Bupropion—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000321	0.00073	CcSEcCtD
Bupropion—Asthenia—Vincristine—lymphatic system cancer	0.000321	0.00073	CcSEcCtD
Bupropion—Diarrhoea—Carmustine—lymphatic system cancer	0.000321	0.000729	CcSEcCtD
Bupropion—Nausea—Bleomycin—lymphatic system cancer	0.000319	0.000725	CcSEcCtD
Bupropion—Asthenia—Mitoxantrone—lymphatic system cancer	0.000313	0.000711	CcSEcCtD
Bupropion—Dizziness—Carmustine—lymphatic system cancer	0.00031	0.000705	CcSEcCtD
Bupropion—Haemoglobin—Methotrexate—lymphatic system cancer	0.000307	0.000698	CcSEcCtD
Bupropion—Diarrhoea—Vincristine—lymphatic system cancer	0.000306	0.000696	CcSEcCtD
Bupropion—Hepatitis—Methotrexate—lymphatic system cancer	0.000306	0.000695	CcSEcCtD
Bupropion—Haemorrhage—Methotrexate—lymphatic system cancer	0.000306	0.000695	CcSEcCtD
Bupropion—Pharyngitis—Methotrexate—lymphatic system cancer	0.000303	0.00069	CcSEcCtD
Bupropion—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000302	0.000686	CcSEcCtD
Bupropion—Urethral disorder—Methotrexate—lymphatic system cancer	0.0003	0.000681	CcSEcCtD
Bupropion—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000298	0.000678	CcSEcCtD
Bupropion—Vomiting—Carmustine—lymphatic system cancer	0.000298	0.000678	CcSEcCtD
Bupropion—Dizziness—Vincristine—lymphatic system cancer	0.000296	0.000673	CcSEcCtD
Bupropion—Rash—Carmustine—lymphatic system cancer	0.000296	0.000672	CcSEcCtD
Bupropion—Dermatitis—Carmustine—lymphatic system cancer	0.000295	0.000671	CcSEcCtD
Bupropion—Visual impairment—Methotrexate—lymphatic system cancer	0.000295	0.00067	CcSEcCtD
Bupropion—Headache—Carmustine—lymphatic system cancer	0.000294	0.000668	CcSEcCtD
Bupropion—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000289	0.000657	CcSEcCtD
Bupropion—Eye disorder—Methotrexate—lymphatic system cancer	0.000286	0.000649	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—lymphatic system cancer	0.000285	0.000648	CcSEcCtD
Bupropion—Vomiting—Vincristine—lymphatic system cancer	0.000285	0.000647	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000284	0.000645	CcSEcCtD
Bupropion—Rash—Vincristine—lymphatic system cancer	0.000282	0.000642	CcSEcCtD
Bupropion—Dermatitis—Vincristine—lymphatic system cancer	0.000282	0.000641	CcSEcCtD
Bupropion—Headache—Vincristine—lymphatic system cancer	0.00028	0.000637	CcSEcCtD
Bupropion—Nausea—Carmustine—lymphatic system cancer	0.000278	0.000633	CcSEcCtD
Bupropion—Angiopathy—Methotrexate—lymphatic system cancer	0.000277	0.000631	CcSEcCtD
Bupropion—Vomiting—Mitoxantrone—lymphatic system cancer	0.000277	0.00063	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—lymphatic system cancer	0.000276	0.000628	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000275	0.000626	CcSEcCtD
Bupropion—Rash—Mitoxantrone—lymphatic system cancer	0.000275	0.000625	CcSEcCtD
Bupropion—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000275	0.000624	CcSEcCtD
Bupropion—Chills—Methotrexate—lymphatic system cancer	0.000274	0.000624	CcSEcCtD
Bupropion—Headache—Mitoxantrone—lymphatic system cancer	0.000273	0.000621	CcSEcCtD
Bupropion—Alopecia—Methotrexate—lymphatic system cancer	0.00027	0.000614	CcSEcCtD
Bupropion—Mental disorder—Methotrexate—lymphatic system cancer	0.000268	0.000609	CcSEcCtD
Bupropion—Malnutrition—Methotrexate—lymphatic system cancer	0.000266	0.000605	CcSEcCtD
Bupropion—Nausea—Vincristine—lymphatic system cancer	0.000266	0.000604	CcSEcCtD
Bupropion—Dysgeusia—Methotrexate—lymphatic system cancer	0.000261	0.000592	CcSEcCtD
Bupropion—Nausea—Mitoxantrone—lymphatic system cancer	0.000259	0.000589	CcSEcCtD
Bupropion—Back pain—Methotrexate—lymphatic system cancer	0.000257	0.000585	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—lymphatic system cancer	0.000251	0.00057	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000247	0.000561	CcSEcCtD
Bupropion—Anaemia—Methotrexate—lymphatic system cancer	0.000246	0.000559	CcSEcCtD
Bupropion—Malaise—Methotrexate—lymphatic system cancer	0.00024	0.000546	CcSEcCtD
Bupropion—Vertigo—Methotrexate—lymphatic system cancer	0.000239	0.000544	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—lymphatic system cancer	0.000238	0.000542	CcSEcCtD
Bupropion—Cough—Methotrexate—lymphatic system cancer	0.000232	0.000528	CcSEcCtD
Bupropion—Convulsion—Methotrexate—lymphatic system cancer	0.000231	0.000524	CcSEcCtD
Bupropion—Myalgia—Methotrexate—lymphatic system cancer	0.000227	0.000515	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—lymphatic system cancer	0.000227	0.000515	CcSEcCtD
Bupropion—Chest pain—Methotrexate—lymphatic system cancer	0.000227	0.000515	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000225	0.000511	CcSEcCtD
Bupropion—Discomfort—Methotrexate—lymphatic system cancer	0.000224	0.000509	CcSEcCtD
Bupropion—Confusional state—Methotrexate—lymphatic system cancer	0.000219	0.000498	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000217	0.000494	CcSEcCtD
Bupropion—Infection—Methotrexate—lymphatic system cancer	0.000216	0.00049	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000213	0.000484	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000213	0.000483	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—lymphatic system cancer	0.000211	0.00048	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00021	0.000477	CcSEcCtD
Bupropion—Anorexia—Methotrexate—lymphatic system cancer	0.000207	0.000471	CcSEcCtD
Bupropion—Hypotension—Methotrexate—lymphatic system cancer	0.000203	0.000461	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000198	0.00045	CcSEcCtD
Bupropion—Insomnia—Methotrexate—lymphatic system cancer	0.000196	0.000447	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—lymphatic system cancer	0.000195	0.000443	CcSEcCtD
Bupropion—Dyspnoea—Methotrexate—lymphatic system cancer	0.000194	0.00044	CcSEcCtD
Bupropion—Somnolence—Methotrexate—lymphatic system cancer	0.000193	0.000439	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—lymphatic system cancer	0.000191	0.000435	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—lymphatic system cancer	0.000189	0.000429	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000187	0.000426	CcSEcCtD
Bupropion—Fatigue—Methotrexate—lymphatic system cancer	0.000187	0.000426	CcSEcCtD
Bupropion—Pain—Methotrexate—lymphatic system cancer	0.000186	0.000422	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000179	0.000407	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000178	0.000404	CcSEcCtD
Bupropion—Urticaria—Methotrexate—lymphatic system cancer	0.000173	0.000392	CcSEcCtD
Bupropion—Abdominal pain—Methotrexate—lymphatic system cancer	0.000172	0.00039	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—lymphatic system cancer	0.000172	0.00039	CcSEcCtD
Bupropion—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00016	0.000364	CcSEcCtD
Bupropion—Asthenia—Methotrexate—lymphatic system cancer	0.000156	0.000354	CcSEcCtD
Bupropion—Pruritus—Methotrexate—lymphatic system cancer	0.000154	0.000349	CcSEcCtD
Bupropion—Diarrhoea—Methotrexate—lymphatic system cancer	0.000149	0.000338	CcSEcCtD
Bupropion—Dizziness—Methotrexate—lymphatic system cancer	0.000144	0.000326	CcSEcCtD
Bupropion—Vomiting—Methotrexate—lymphatic system cancer	0.000138	0.000314	CcSEcCtD
Bupropion—Rash—Methotrexate—lymphatic system cancer	0.000137	0.000311	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—lymphatic system cancer	0.000137	0.000311	CcSEcCtD
Bupropion—Headache—Methotrexate—lymphatic system cancer	0.000136	0.000309	CcSEcCtD
Bupropion—Nausea—Methotrexate—lymphatic system cancer	0.000129	0.000293	CcSEcCtD
